148 related articles for article (PubMed ID: 22743290)
1. Cytochrome P450 2A13 mediates aflatoxin B1-induced cytotoxicity and apoptosis in human bronchial epithelial cells.
Yang XJ; Lu HY; Li ZY; Bian Q; Qiu LL; Li Z; Liu Q; Li J; Wang X; Wang SL
Toxicology; 2012 Oct; 300(3):138-48. PubMed ID: 22743290
[TBL] [Abstract][Full Text] [Related]
2. Cytochrome P450 2A13 enhances the sensitivity of human bronchial epithelial cells to aflatoxin B1-induced DNA damage.
Yang X; Zhang Z; Wang X; Wang Y; Zhang X; Lu H; Wang SL
Toxicol Appl Pharmacol; 2013 Jul; 270(2):114-21. PubMed ID: 23602888
[TBL] [Abstract][Full Text] [Related]
3. Cytochrome P450 2A13 mediates the neoplastic transformation of human bronchial epithelial cells at a low concentration of aflatoxin B1.
Zhang Z; Lu H; Huan F; Meghan C; Yang X; Wang Y; Wang X; Wang X; Wang SL
Int J Cancer; 2014 Apr; 134(7):1539-48. PubMed ID: 24114584
[TBL] [Abstract][Full Text] [Related]
4. Comparative aflatoxin B(1) activation and cytotoxicity in human bronchial cells expressing cytochromes P450 1A2 and 3A4.
Van Vleet TR; Macé K; Coulombe RA
Cancer Res; 2002 Jan; 62(1):105-12. PubMed ID: 11782366
[TBL] [Abstract][Full Text] [Related]
5. Nicotine Component of Cigarette Smoke Extract (CSE) Decreases the Cytotoxicity of CSE in BEAS-2B Cells Stably Expressing Human Cytochrome P450 2A13.
Ji M; Zhang Y; Li N; Wang C; Xia R; Zhang Z; Wang SL
Int J Environ Res Public Health; 2017 Oct; 14(10):. PubMed ID: 29027939
[TBL] [Abstract][Full Text] [Related]
6. Cytochrome P450 2A13 is an efficient enzyme in metabolic activation of aflatoxin G1 in human bronchial epithelial cells.
Zhang Z; Yang X; Wang Y; Wang X; Lu H; Zhang X; Xiao X; Li S; Wang X; Wang SL
Arch Toxicol; 2013 Sep; 87(9):1697-707. PubMed ID: 23907605
[TBL] [Abstract][Full Text] [Related]
7. miR-138-1* regulates aflatoxin B1-induced malignant transformation of BEAS-2B cells by targeting PDK1.
Wang Y; Zhang Z; Wang H; Zhang Y; Ji M; Xu H; Wang C; Sun Z; Gao W; Wang SL
Arch Toxicol; 2016 May; 90(5):1239-49. PubMed ID: 26084420
[TBL] [Abstract][Full Text] [Related]
8. Metabolism and cytotoxicity of aflatoxin b1 in cytochrome p-450-expressing human lung cells.
Van Vleet TR; Klein PJ; Coulombe RA
J Toxicol Environ Health A; 2002 Jun; 65(12):853-67. PubMed ID: 12079611
[TBL] [Abstract][Full Text] [Related]
9. Aflatoxin B1 alters the expression of p53 in cytochrome P450-expressing human lung cells.
Van Vleet TR; Watterson TL; Klein PJ; Coulombe RA
Toxicol Sci; 2006 Feb; 89(2):399-407. PubMed ID: 16280384
[TBL] [Abstract][Full Text] [Related]
10. Oltipraz-mediated changes in aflatoxin B(1) biotransformation in rat liver: implications for human chemointervention.
Buetler TM; Bammler TK; Hayes JD; Eaton DL
Cancer Res; 1996 May; 56(10):2306-13. PubMed ID: 8625305
[TBL] [Abstract][Full Text] [Related]
11. Optimization of heme precursors for the expression of human cytochrome P450 2A13 and its co-expression with oxidoreductase in baculovirus/sf9 system.
Lu HY; Qiu LL; Yang XJ; Zhang XM; Zhang Z; Wang SL
J Biochem; 2013 Jun; 153(6):555-63. PubMed ID: 23463547
[TBL] [Abstract][Full Text] [Related]
12. Identification of 5-hydroxymethylfurfural in cigarette smoke extract as a new substrate metabolically activated by human cytochrome P450 2A13.
Ji M; Zhang Z; Li N; Xia R; Wang C; Yu Y; Yao S; Shen J; Wang SL
Toxicol Appl Pharmacol; 2018 Nov; 359():108-117. PubMed ID: 30253172
[TBL] [Abstract][Full Text] [Related]
13. The missense genetic polymorphisms of human CYP2A13: functional significance in carcinogen activation and identification of a null allelic variant.
Wang SL; He XY; Shen J; Wang JS; Hong JY
Toxicol Sci; 2006 Nov; 94(1):38-45. PubMed ID: 16917071
[TBL] [Abstract][Full Text] [Related]
14. Metabolism of aflatoxin B1 by normal human bronchial epithelial cells.
Van Vleet TR; Klein PJ; Coulombe RA
J Toxicol Environ Health A; 2001 Aug; 63(7):525-40. PubMed ID: 11497333
[TBL] [Abstract][Full Text] [Related]
15. Effects of 8-methoxypsoralen on cytochrome P450 2A13.
von Weymarn LB; Zhang QY; Ding X; Hollenberg PF
Carcinogenesis; 2005 Mar; 26(3):621-9. PubMed ID: 15579482
[TBL] [Abstract][Full Text] [Related]
16. Efficient activation of aflatoxin B1 by cytochrome P450 2A13, an enzyme predominantly expressed in human respiratory tract.
He XY; Tang L; Wang SL; Cai QS; Wang JS; Hong JY
Int J Cancer; 2006 Jun; 118(11):2665-71. PubMed ID: 16385575
[TBL] [Abstract][Full Text] [Related]
17. CYP2A13 Acts as the Main Metabolic CYP450s Enzyme for Activating Leonurine in Human Bronchial Epithelial Cells.
Xu T; Li X; Leng T; Zhuang T; Sun Y; Tang Y; Wang L; Yang M; Ji M
Med Sci Monit; 2020 Apr; 26():e922149. PubMed ID: 32284524
[TBL] [Abstract][Full Text] [Related]
18. CYP2A13 in human respiratory tissues and lung cancers: an immunohistochemical study with a new peptide-specific antibody.
Zhu LR; Thomas PE; Lu G; Reuhl KR; Yang GY; Wang LD; Wang SL; Yang CS; He XY; Hong JY
Drug Metab Dispos; 2006 Oct; 34(10):1672-6. PubMed ID: 16815959
[TBL] [Abstract][Full Text] [Related]
19. The formation of AFB(1)-macromolecular adducts in rats and humans at dietary levels of exposure.
Cupid BC; Lightfoot TJ; Russell D; Gant SJ; Turner PC; Dingley KH; Curtis KD; Leveson SH; Turteltaub KW; Garner RC
Food Chem Toxicol; 2004 Apr; 42(4):559-69. PubMed ID: 15019179
[TBL] [Abstract][Full Text] [Related]
20. Variability in aflatoxin B(1)-macromolecular binding and relationship to biotransformation enzyme expression in human prenatal and adult liver.
Doi AM; Patterson PE; Gallagher EP
Toxicol Appl Pharmacol; 2002 May; 181(1):48-59. PubMed ID: 12030842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
